BA
Brian Abrahams RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
98
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
60.8%
Neutral
38.2%
Negative
1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $58 |
35%
upside
| 4 | +4.9% |
0
%
| 4 Nov ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $19 |
108%
upside
| 2 | +25% |
0
%
| 4 Nov ‘25 4 months ago |
|
|
|
Sector Perform
Maintained
| $11 | – | 1 | – |
–
| 8 Aug ‘25 6 months ago |
|
|
|
Sector Perform
Maintained
| $23 |
43%
upside
| 3 | -34% |
–
| 17 Jul ‘25 7 months ago |
|
|
|
Sector Perform
Reiterated
| $1.50 | – | 1 | – |
–
| 14 May ‘25 9 months ago |
|
|
|
Outperform
Reiterated
| $84 |
371%
upside
| 1 | -45% |
0
%
| 22 Apr ‘25 10 months ago |
|